학술논문
Health-related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study
Document Type
Article
Author
Sanchorawala, V.; Palladini, G.; Merlini, G.; Minnema, M.C.; Jaccard, A.; Lee, H.C.; Gibbs, S.; Mollee, P.; Venner, C.; Lu, J.; Schönland, S.; Gatt, M.; Suzuki, K.; Kim, K.; Cibeira, M.T.; Beksac, M.; Libby, E.; Valent, J.; Hungria, V.; Wong, S.W.; Rosenzweig, M.; Bumma, N.; Chauveau, D.; Gries, K.S.; Fastenau, J.; Tran, N.P.; Qin, X.; Vasey, S.Y.; Weiss, B.M.; Vermeulen, J.; Ho, K.F.; Comenzo, R.L.; Kastritis, E.; Wechalekar, A.D.
Source
In: American Journal of Hematology . (American Journal of Hematology, 1 June 2022, 97(6):719-730)
Subject
Language
English
ISSN
10968652
03618609
03618609